(Q80467290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Is there increasing evidence that the risks of rhAPC may outweigh its benefits? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Maria Plataki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Katerina Vaporidi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dimitris Georgopoulos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

12 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

published in

Intensive Care Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1485-6; author reply 1489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00134-007-0707-y

31 December 2019

exact match

0 references

cites work

Increasing evidence that the risks of rhAPC may outweigh its benefits.

1 reference

12 December 2020

Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study.

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

12 December 2020

Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey

1 reference

12 December 2020

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

12 December 2020

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

1 reference

12 December 2020

10.1007/S00134-007-0707-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563880%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference